Birdwatch Note
2024-10-01 16:15:18 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The autoimmune condition defining Type 1 diabetes was not cured. The patient is dependent on life-long immunosuppressant drugs, with serious side effects, to avoid the autoimmune response killing the new cells, too. Verify: search for "immunosuppression" in the paper here: https://www.sciencedirect.com/science/article/pii/S0092867424010225?casa_token=0-SPwDIgApoAAAAA:Vj-uccU-x2GXBUiGsP7EU7KxNtELDC1HzqdYNirN2YLWtDf5mjW0_fQOhAoFTRfk1cjzW0vOtPxG
Written by 7136D77377C6430080F3B133D0D94340C49657DD27F11ADC00263DA88CAC9729
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1840838143635042732
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841149903319220583
- noteId - 1841149903319220583
- participantId -
- noteAuthorParticipantId - 7136D77377C6430080F3B133D0D94340C49657DD27F11ADC00263DA88CAC9729 Participant Details
- createdAtMillis - 1727799318520
- tweetId - 1840838143635042732
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The autoimmune condition defining Type 1 diabetes was not cured. The patient is dependent on life-long immunosuppressant drugs, with serious side effects, to avoid the autoimmune response killing the new cells, too. Verify: search for "immunosuppression" in the paper here: https://www.sciencedirect.com/science/article/pii/S0092867424010225?casa_token=0-SPwDIgApoAAAAA:Vj-uccU-x2GXBUiGsP7EU7KxNtELDC1HzqdYNirN2YLWtDf5mjW0_fQOhAoFTRfk1cjzW0vOtPxG
Note Ratings
| rated at | rated by | |
| 2024-10-02 13:18:25 -0500 | Rating Details | |
| 2024-10-02 13:08:57 -0500 | Rating Details | |
| 2024-10-02 12:53:01 -0500 | Rating Details | |
| 2024-10-02 10:33:32 -0500 | Rating Details | |
| 2024-10-02 09:03:42 -0500 | Rating Details | |
| 2024-10-02 08:32:28 -0500 | Rating Details | |
| 2024-10-02 08:22:05 -0500 | Rating Details | |
| 2024-10-02 07:33:50 -0500 | Rating Details | |
| 2024-10-02 06:48:53 -0500 | Rating Details | |
| 2024-10-02 06:20:45 -0500 | Rating Details | |
| 2024-10-02 06:15:04 -0500 | Rating Details | |
| 2024-10-02 06:08:18 -0500 | Rating Details | |
| 2024-10-02 05:26:04 -0500 | Rating Details | |
| 2024-10-02 04:51:00 -0500 | Rating Details | |
| 2024-10-02 04:08:38 -0500 | Rating Details | |
| 2024-10-02 03:06:07 -0500 | Rating Details | |
| 2024-10-02 02:35:35 -0500 | Rating Details | |
| 2024-10-02 01:59:24 -0500 | Rating Details | |
| 2024-10-02 01:55:52 -0500 | Rating Details | |
| 2024-10-02 01:11:40 -0500 | Rating Details | |
| 2024-10-02 00:26:30 -0500 | Rating Details | |
| 2024-10-01 23:17:09 -0500 | Rating Details | |
| 2024-10-01 22:58:07 -0500 | Rating Details | |
| 2024-10-01 22:53:50 -0500 | Rating Details | |
| 2024-10-01 20:54:58 -0500 | Rating Details | |
| 2024-10-01 20:52:13 -0500 | Rating Details | |
| 2024-10-01 20:42:24 -0500 | Rating Details | |
| 2024-10-01 20:41:14 -0500 | Rating Details | |
| 2024-10-01 19:46:14 -0500 | Rating Details | |
| 2024-10-01 18:36:19 -0500 | Rating Details | |
| 2024-10-01 18:18:39 -0500 | Rating Details | |
| 2024-10-01 17:53:57 -0500 | Rating Details | |
| 2024-10-01 17:45:02 -0500 | Rating Details | |
| 2024-10-01 17:09:53 -0500 | Rating Details | |
| 2024-10-01 17:02:54 -0500 | Rating Details | |
| 2024-10-01 16:03:10 -0500 | Rating Details | |
| 2024-10-01 15:48:53 -0500 | Rating Details | |
| 2024-10-01 15:14:37 -0500 | Rating Details | |
| 2024-10-01 15:04:09 -0500 | Rating Details | |
| 2024-10-01 14:54:10 -0500 | Rating Details | |
| 2024-10-01 14:43:26 -0500 | Rating Details | |
| 2024-10-01 14:30:37 -0500 | Rating Details | |
| 2024-10-01 13:43:34 -0500 | Rating Details | |
| 2024-10-01 13:28:09 -0500 | Rating Details | |
| 2024-10-01 13:19:21 -0500 | Rating Details | |
| 2024-10-01 13:11:05 -0500 | Rating Details | |
| 2024-10-01 13:08:23 -0500 | Rating Details | |
| 2024-10-01 12:43:07 -0500 | Rating Details | |
| 2024-10-01 12:22:50 -0500 | Rating Details | |
| 2024-10-01 12:17:03 -0500 | Rating Details | |
| 2024-10-01 11:57:27 -0500 | Rating Details | |
| 2024-10-01 11:48:34 -0500 | Rating Details | |
| 2024-10-01 11:41:01 -0500 | Rating Details | |
| 2024-10-01 11:40:59 -0500 | Rating Details | |
| 2024-10-01 11:25:27 -0500 | Rating Details | |
| 2024-10-02 14:16:46 -0500 | Rating Details | |
| 2024-10-02 13:42:43 -0500 | Rating Details | |
| 2024-10-02 03:46:08 -0500 | Rating Details | |
| 2024-10-02 01:52:34 -0500 | Rating Details | |
| 2024-10-02 00:57:57 -0500 | Rating Details | |
| 2024-10-02 00:52:15 -0500 | Rating Details | |
| 2024-10-01 18:55:56 -0500 | Rating Details | |
| 2024-10-01 18:04:38 -0500 | Rating Details | |
| 2024-10-01 17:26:44 -0500 | Rating Details | |
| 2024-10-01 14:35:07 -0500 | Rating Details | |
| 2024-10-01 13:19:32 -0500 | Rating Details | |
| 2024-10-01 12:53:54 -0500 | Rating Details | |
| 2024-10-01 12:33:10 -0500 | Rating Details | |
| 2024-10-01 12:06:46 -0500 | Rating Details | |
| 2024-10-01 11:38:20 -0500 | Rating Details | |
| 2024-10-02 14:45:02 -0500 | Rating Details | |
| 2024-10-02 09:24:02 -0500 | Rating Details | |
| 2024-10-01 22:27:28 -0500 | Rating Details | |
| 2024-10-01 21:52:59 -0500 | Rating Details | |
| 2024-10-01 20:41:20 -0500 | Rating Details | |
| 2024-10-01 14:20:48 -0500 | Rating Details | |
| 2024-10-01 14:07:14 -0500 | Rating Details | |
| 2024-10-02 03:53:48 -0500 | Rating Details | |
| 2024-10-02 00:53:52 -0500 | Rating Details | |
| 2024-10-01 16:54:12 -0500 | Rating Details | |
| 2024-10-01 13:13:42 -0500 | Rating Details | |
| 2024-10-01 12:44:25 -0500 | Rating Details | |
| 2024-10-01 11:26:24 -0500 | Rating Details |